IBM stock holds key support as recovery continues

IBM stock holds key support as recovery continues
Recovery remains intact above $230.

​IBM stock continues to recover from its July sell-off, holding above the key $230 area despite a weak trading session on August 6. The previously identified $244 target remains valid, while a sustained move above it could open the way to a broader recovery.

On August 6, IBM fell 1.06% to $233.43, but the decline came amid broader weakness in the U.S. equity market: the Dow Jones lost 0.85%, while the S&P 500 declined 0.18%. At the same time, no new negative corporate catalyst emerged. This suggests that the pullback is more likely a period of short-term profit-taking after the recovery from July lows rather than a renewed wave of selling.

Recovery setup remains intact while $230 holds

The previously outlined scenario has partially materialized. After decisively breaking above resistance near $230, IBM shares continued higher and approached $240, although the $244 target has not yet been reached. A moderate pullback followed.

The base-case scenario therefore remains largely unchanged. Holding $230 would preserve the probability of another attempt toward $244. A successful breakout above this level could extend the recovery toward the $260–270 area,where the 50-day and 200-day SMAs are located.

A break below $230 would weaken the short-term structure and increase the probability of a return toward $220. For now, however, this scenario appears less likely.

IBM recovery may require time or a stronger catalyst 

Despite the improving short-term technical picture, the current move still looks more like a recovery from the sharp July decline than the beginning of a full return toward previous highs.

Even if IBM establishes a sustained position above $244 and continues toward $260–270, the stock would remain well below its previous peaks. A return to those levels would likely require either a prolonged period of gradual recovery or a stronger fundamental catalyst capable of materially improving investor expectations for IBM’s growth outlook.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.